Research Paper Volume 16, Issue 4 pp 4033—4051

LGALS3BP is a novel and potential biomarker in clear cell renal cell carcinoma

class="figure-viewer-img"

Figure 7. LGALS3BP has been implicated in immune and urological diseases.